Abstract
Although the neurochemical anatomy of many pathways in human brain has been studied, little attention has been paid to the human pyramidal system. This pathway is very important for voluntary motor control in vertebrates, and pyramidal tract pathology leads to hemiparesis or hemiplegia in primates and man (Phillips and Porter, 1977). Identification of the neurotransmitter of the pyramidal tract would allow a more systematic investigation of drugs for the treatment of the neurological consequences of stroke, spinal cord and head trauma, multiple sclerosis, amyotrophic lateral sclerosis and cerebral palsy.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bromberg, M.B., Penney Jr., J.B., Stephenson, B.S. and Young, A.B. (1981). Evidence for glutamate as the neurotransmitter of corticothalamic and corticorubral pathways. Brain Res., 215, 369–374.
Divac, I., Fonnum, F. and Storm-Mathisen, J. (1977). High affinity uptake of glutamate in terminals of corticostriatal axons. Nature, 266, 377–378.
Fink, R.P. and Heimer, L. (1967). Two methods for selective impregnation of degenerating axons and their synaptic endings in the central nervous system. Brain Res., 4, 369–374.
Fonnum, R., Soreide, A., Kvale, I., Walker, J. and Walaas, I. (1981). Glutamate in cortical fibers. Biochem. Psychopharmacol., 27. 29–42.
Foster, N.L., Chase, T.N., Fedio, P., Petronas, N.J., Brooks, R.A., and DiChiro, G. (1983). Alzheimer’s disease: Focal cortical changes shown by positron emission tomography. Neurology, 33, 961–965.
Greenamyre, J.T., Olson, J.M.M., Penney, J.B. and Young, A.B. (1985a). Autoradiographic characterization of N-methyl-D-aspartate-, quisqualate- and kainate-sensitive glutamate binding sites. J. Pharmacol. Exp. Ther., 233, 254–263.
Greenamyre, J.T., Penney, J.B., Young, A.B., D’Amato, C.J., Hicks, S.P. and Shoulson, I. (1985b). Alterations in L-glutamate binding in Alzheimer’s and Huntington’s diseases. Science, 227, 1496–1499.
Greenamyre, J.T., Young, A.B. and Penney, J.B. (1983). Quantitative autoradiography of L-[3H]glutamate binding to rat brain. Neurosci. Lett., 37, 155–160.
Greenamyre, J.T., Young, A.B. and Penney. J.B. (1984). Quantitative autoradiographic distribution of L-[3H]glutamate binding sites in rat central nervous system. J. Neurosci., 4, 2133–2144.
Halpain, S.H., Parsons, B. and Rainbow, T.C. (1983). Tritium-film autoradiography of sodium-independent glutamate binding sites in rat brain. Eur. J. Pharmacol., 86, 313–314.
Halpaln, S.H., Wieczorek, C.M. and Rainbow, T.C (1984). Localization of L-glutamate receptors in rat brain by quantitative autoradiography. J. Neurosci., 4, 2247–2258.
Kim, J.S., Hassler, R., Haug, P. and Paik, K.-S. (1977). Effect of frontal cortex ablation on striatal glutamic acid level in the rat. Brain Res., 132, 370–374.
Kuypers, H.G.J.M. (1981). Anatomy of the descending pathways. In Handbook of Physiology: The Nervous System II. (ed. V.B. Brooks). American Physiology Society, Washington, D.C
Lynch, G. and Baudry, M. (1984). The biochemistry of memory: A new and specific hypothesis. Science, 224, 1057–1063.
McGeer, P.L., McGeer, E.G., Scherer, U. and Singh, K. (1977). A glutamatergic corticostriatal path? Brain Res., 128, 369–373.
Monaghan, D.T., Holets, V.R., Toy, D.W. and Cotman, C.W. (1983). Anatomical distributions of four pharmacologically distinct 3H-L-glutamate binding sites. Nature, 306, 176–179.
Phillips, C.G. and Porter, R. (1977). Corticospinal Neurones: Their Role in Movement. Academic Press, New York.
Shoulson, I. (1984a). Huntington’s disease: Anti-neurotoxic therapeutic strategies. In Excitotoxins. (eds. K. Fuxe, P. Roberts and R. Schwarcz). Plenum Press, New York.
Shoulson, I. (1984b). Huntington’s disease: A decade of progress. Neurologic Clin., 2, 515–526.
Stone, T.W. (1979). Amino acids as neurotransmitter of cortico-fugal neurones in the rat: A comparison of glutamate and aspartate. Br. J. Pharmacol., 67, 545–551.
Terry, R.D. and Katzman, R. (1983). Senile dementia of the Alzheimer type. Ann. Neurol., 14, 497–506.
Thangnipon, W. and Storm-Mathisen, J. (1981). K+-evoked Ca2+-de-pendent release of D-[3H]asparate from terminals of the corticopontine pathway. Neurosci. Lett., 23 181–186.
Thangnipon, W., Taxt, T., Brodai, P. and Storm-Mathisen, J. (1983). The cortico-pontine projection: axotomy-induced loss of high affinity L-glutamate and Daspartate uptake, but not of GABA uptake, glutamate decarboxylase or choline acetyltransferase, in the pontine nuclei. Neuroscience, 8, 449–458.
Young, A.B., Bromberg, M.B. and Penney Jr., J.B. (1981). Decreased glutamate uptake in subcortical areas deafferented by sensorimotor cortical ablation in the cat. J. Neurosci., 1, 241–249.
Young, A.B., Penney, J.B., Dauth, G.W., Bromberg, M.B. and Gilman, S. (1983). Glutamate or aspartate as a possible neurotransmitter of cerebral corticofugal fibers in the monkey. Neurology, 33, 1513–1516.
Editor information
Editors and Affiliations
Copyright information
© 1986 The Editors and the Contributors
About this chapter
Cite this chapter
Young, A.B., Greenamyre, J.T., Penney, J.B., Bromberg, M.B. (1986). Glutamate Receptors and Glutamate Corticofugal Pathways. In: Roberts, P.J., Storm-Mathisen, J., Bradford, H.F. (eds) Excitatory Amino Acids. Palgrave Macmillan, London. https://doi.org/10.1007/978-1-349-08479-1_23
Download citation
DOI: https://doi.org/10.1007/978-1-349-08479-1_23
Publisher Name: Palgrave Macmillan, London
Print ISBN: 978-1-349-08481-4
Online ISBN: 978-1-349-08479-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)